Selected Coastal Plants as Potential Treatment for Pneumonia Disease: Determination of Their Phytochemicals and Antibacterial Activity Against some Pneumonia Bacteria
-
Published:2023-12-27
Issue:6
Volume:39
Page:1479-1494
-
ISSN:2231-5039
-
Container-title:Oriental Journal Of Chemistry
-
language:en
-
Short-container-title:Orient. J. Chem
Author:
Hanifah Wahdini1ORCID, Andriani Yosie1ORCID, Zin Nor Atikah Mohamed1, Ryandini Dini2, Abdul Majid Fadzillah Adibah1ORCID, Subhan eginer3ORCID, Muhammad Tengku Sifzizul Tengku1ORCID
Affiliation:
1. 1Institute of Climate Adaptation and Marine Biotechnology, Universiti Malaysia Terengganu, Mengabang Telipot 21030, Kuala Nerus, Terengganu, Malaysia. 2. 2Microbiology Department, Faculty of Biology, Universitas Jenderal Soedirman, Purwokerto, Central Java, Indonesia. 3. 3Faculty of Fisheries and Marine Sciences, Institut Pertanian Bogor, Bogor, West Java, Indonesia.
Abstract
Pneumonia is a respiratory infection caused by microorganisms including bacteria. Current treatment with antibiotics leads to bacterial resistance. An alternative treatment involves utilizing coastal plants. In this study, five parts of eleven coastal plants underwent phytochemicals screening and investigated for their antibacterial activity against five pneumonia bacteria. Cold extraction was performed using hexane and methanol, successively. Qualitative phytochemicals screening and antibacterial testing were done using several reagents and agar well diffusion method, respectively. The results revealed that almost all hexane and methanolic fractions from coastal plants showed antibacterial activity, except Vitex rotundifolia leaves. The highest activity was shown by hexane fraction of Rhodomyrtus tomentosa leaves. Among the methanolic fractions, Syzigium grande twigs exhibited the highest antibacterial property. Phytochemical screening revealed the presence of flavonoids in all active fractions, potentially correlating with their antibacterial activity. In summary, some selected coastal plants have the potential to act as anti-pneumonia bacteria agents.
Publisher
Oriental Scientific Publishing Company
Subject
Drug Discovery,Environmental Chemistry,Biochemistry,General Chemistry
Reference70 articles.
1. 1. Woodruff, P. G.; Van, D. B. M.; Boucher, R. C.; Brightling, C.; Burchard, E. G.; Christenson, S. A.; Han, M. K.; Holtzman, M. J.; Kraft, M.; Lynch, D. A.; Martinez, F. D.; Reddel, H. K.; Sin, D. D.; Washko, G. R.; Wenzel, S. E.; Punturieri, A.; Freemer, M. M.; Wise, R. A. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report. Am. J. Respir. Crit. Care Med. 2017, 196 (3), 375–381. https://doi.org/10.1164/rccm.201705-0973WS. 2. 2. Espada-Sánchez, M.; Sáenz de Santa María, R.; Martín-Astorga, M. del C.; Lebrón-Martín, C.; Delgado, M. J.; Eguiluz-Gracia, I.; Rondón, C.; Mayorga, C.; Torres, M. J.; Aranda, C. J.; Cañas, J. A. Diagnosis and Treatment in Asthma and Allergic Rhinitis: Past, Present, and Future. Appl. Sci. 2023, 13 (3). https://doi.org/10.3390/app13031273. 3. 3. Geddes, D. The History of Respiratory Disease Management. Medicine (Baltimore). 2016, 44 (6), 393–397. 4. 4. Macias, A. E.; McElhaney, J. E.; Chaves, S. S.; Nealon, J.; Nunes, M. C.; Samson, S. I.; Seet, B. T.; Weinke, T.; Yu, H. The Disease Burden of Influenza beyond Respiratory Illness. Vaccine 2021, 39, A6–A14. https://doi.org/10.1016/j.vaccine.2020.09.048. 5. 5. Krishna, R.; Chapman, K.; Ullah, S. Idiopathic Pulmonary Fibrosis; StatPearls Publishing, Treasure Island (FL), 2023.
|
|